Literature DB >> 2039157

Renal involvement in tuberous sclerosis.

J Bernstein1, T O Robbins.   

Abstract

TSC in the kidney is expressed principally as renal cysts and angiomyolipomas. Both abnormalities may occur separately or together, and both are commonly multiple and bilateral. Cystic disease is sometimes so severe as to be confused with polycystic kidney disease, although the histopathologic findings are practically diagnostic of TSC. Severe cystic disease causes renal insufficiency; large angiomyolipomas predispose to life-threatening hemorrhage. Renal malignancies have been reported in what appears to be a significant number of patients. We hypothesize that the renal abnormalities result from cell hyperplasia and hypertrophy, much like the other abnormalities of tuberous sclerosis, such as cerebral tubers and cardiac rhabdomyomas. The renal abnormalities can therefore be regarded as an expression of the TSC gene, and their recognition as such carries importance for treatment and counseling.

Entities:  

Mesh:

Year:  1991        PMID: 2039157     DOI: 10.1111/j.1749-6632.1991.tb37746.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  23 in total

Review 1.  New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.

Authors:  Hilaire C Lam; Julie Nijmeh; Elizabeth P Henske
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

2.  Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas.

Authors:  Jay H Ryu; Thomas E Hartman; Vicente E Torres; Paul A Decker
Journal:  Chest       Date:  2011-07-07       Impact factor: 9.410

3.  Tuberous sclerosis and polycystic kidney disease.

Authors:  D W Webb; M Super; I C Normand; J P Osborne
Journal:  BMJ       Date:  1993-05-08

4.  Concurrent bilateral renal angiomyolipoma and renal cell carcinoma in a patient with tuberous sclerosis complex.

Authors:  Abdelhak Khallouk; Younes Ahallal; Mbarek Doublali; Mohamed Fadl Tazi; Soufiane Mellas; Mohamed Jamal El Fassi; Moulay Hassan Farih
Journal:  Rev Urol       Date:  2009

Review 5.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

6.  Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.

Authors:  E P Henske; L L Wessner; J Golden; B W Scheithauer; A O Vortmeyer; Z Zhuang; A J Klein-Szanto; D J Kwiatkowski; R S Yeung
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

Review 7.  Association of angiomyolipoma and oncocytoma of the kidney: a case report and review of the literature.

Authors:  K Pillay; J Lazarus; H C Wainwright
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 8.  Renal cystic disease in the tuberous sclerosis complex.

Authors:  J Bernstein
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  Renal involvement in tuberous sclerosis complex: a retrospective survey.

Authors:  L B Zimmerhackl; M Rehm; K Kaufmehl; G Kurlemann; M Brandis
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

10.  Unilateral simultaneous renal oncocytoma and angiomyolipoma: case report.

Authors:  Theodosios Theodosopoulos; Anneza Yiallourou; Maria Kyriazi; Georgios Anastasopoulos; Evi Kairi-Vassilatou; Nicolaos Dafnios; Ioannis Vassiliou
Journal:  Cases J       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.